共 59 条
[1]
Mannino DM(2006)Changing the burden of COPD mortality Int J Chron Obstruct Pulmon Dis. 1 219-233
[2]
Kiriz VA(2017)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Am J Respir Crit Care Med. 195 557-582
[3]
Vogelmeier CF(2015)Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit PLoS One. 10 e0124374-59
[4]
Criner GJ(2011)Guidelines for the management of adult lower respiratory tract infections--full version Clin Microbiol Infect. 17 E1-1270
[5]
Martinez FJ(2002)Pneumonic vs nonpneumonic acute exacerbations of COPD Chest. 122 1264-12
[6]
Lopez-Campos JL(2009)Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis. 48 1-180
[7]
Hartl S(2000)Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options J Infect Dis. 181 176-60
[8]
Pozo-Rodriguez F(2009)Prognostic value of procalcitonin in Legionella pneumonia Eur J Clin Microbiol Infect Dis. 28 55-404
[9]
Roberts CM(2001)Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis J Clin Endocrinol Metab. 86 396-573
[10]
Woodhead M(2007)Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur Respir J. 30 556-2708